Alembic Pharmaceuticals share value falls 4% in the intraday trade on March 16:
To begin with, today, the share value of the Alembic Pharmaceuticals declined by around 4% in the morning session trade. When the company got 4 investigation reports by the US Food and Drug Administration.
Moreover, the USFDA inspected in a general oral solid formulation of Alembic Pharma in Panelav. The US-based organization conducted an inspection from 9th March to 13th March 2020. It was a planned investigation process.
The USFDA provided a from 483 for the 4 operational observations by the ending of the investigation process. Also, anyone of the observations not related to integrity or in the repetitive nature.
The company also issued a corrective comprehensive action report to address the 4 observations. Moreover, it agreed to proved high-quality standards that reach USFDA standards.
At 09:27 am, the Alembic Pharmaceuticals has traded at Rs 550 per equity share with a loss of 4.35% or 25.00 points on the Bombay Stock Exchange.
Alembic Pharmaceuticals Ltd shares trading with a loss of 50.40 points reached 523.75 INR with 8.78% down. Its previous close at 574.15 INR on the National Stock Exchange. Alembic Pharma Ltd shares outstanding with 188,500,000.
Besides, the Sensex and Nifty trading with a bearish trend today (March 16th), The Sensex trading with a loss of 2,430.64 points reached 31,672.84 with 7.13% down.